Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Risk factors in the development of stem cell therapy.

Herberts CA, Kwa MS, Hermsen HP.

J Transl Med. 2011 Mar 22;9:29. doi: 10.1186/1479-5876-9-29.

2.

Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease.

Itoh N, Ornitz DM.

J Biochem. 2011 Feb;149(2):121-30. doi: 10.1093/jb/mvq121. Review.

3.

Neurogenic characteristics of placental stem cells in preeclampsia.

Portmann-Lanz CB, Baumann MU, Mueller M, Wagner AM, Weiss S, Haller O, Sager R, Reinhart U, Surbek DV.

Am J Obstet Gynecol. 2010 Oct;203(4):399.e1-7. doi: 10.1016/j.ajog.2010.06.054.

PMID:
20723871
4.

Epithelial repair mechanisms in the lung.

Crosby LM, Waters CM.

Am J Physiol Lung Cell Mol Physiol. 2010 Jun;298(6):L715-31. doi: 10.1152/ajplung.00361.2009. Review.

5.

Mesenchymal stem cells in human placental chorionic villi reside in a vascular Niche.

Castrechini NM, Murthi P, Gude NM, Erwich JJ, Gronthos S, Zannettino A, Brennecke SP, Kalionis B.

Placenta. 2010 Mar;31(3):203-12. doi: 10.1016/j.placenta.2009.12.006.

PMID:
20060164
6.

Multipotent mesenchymal stem cells from human placenta: critical parameters for isolation and maintenance of stemness after isolation.

Semenov OV, Koestenbauer S, Riegel M, Zech N, Zimmermann R, Zisch AH, Malek A.

Am J Obstet Gynecol. 2010 Feb;202(2):193.e1-193.e13. doi: 10.1016/j.ajog.2009.10.869.

PMID:
20035913
7.

Human placenta is a potent hematopoietic niche containing hematopoietic stem and progenitor cells throughout development.

Robin C, Bollerot K, Mendes S, Haak E, Crisan M, Cerisoli F, Lauw I, Kaimakis P, Jorna R, Vermeulen M, Kayser M, van der Linden R, Imanirad P, Verstegen M, Nawaz-Yousaf H, Papazian N, Steegers E, Cupedo T, Dzierzak E.

Cell Stem Cell. 2009 Oct 2;5(4):385-95. doi: 10.1016/j.stem.2009.08.020.

8.

Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung.

Lee JW, Fang X, Gupta N, Serikov V, Matthay MA.

Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16357-62. doi: 10.1073/pnas.0907996106.

9.

Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis.

Cargnoni A, Gibelli L, Tosini A, Signoroni PB, Nassuato C, Arienti D, Lombardi G, Albertini A, Wengler GS, Parolini O.

Cell Transplant. 2009;18(4):405-22. doi: 10.3727/096368909788809857.

PMID:
19622228
10.

Human term placenta as a source of hematopoietic cells.

Serikov V, Hounshell C, Larkin S, Green W, Ikeda H, Walters MC, Kuypers FA.

Exp Biol Med (Maywood). 2009 Jul;234(7):813-23. doi: 10.3181/0809-BC-262.

11.

Stem cells use distinct self-renewal programs at different ages.

Levi BP, Morrison SJ.

Cold Spring Harb Symp Quant Biol. 2008;73:539-53. doi: 10.1101/sqb.2008.73.049. Review.

PMID:
19150957
12.

The human placenta is a hematopoietic organ during the embryonic and fetal periods of development.

Bárcena A, Kapidzic M, Muench MO, Gormley M, Scott MA, Weier JF, Ferlatte C, Fisher SJ.

Dev Biol. 2009 Mar 1;327(1):24-33. doi: 10.1016/j.ydbio.2008.11.017. Retraction in: Dev Biol. 2014 Apr 15;388(2):216.

13.

Comparison of human placenta- and bone marrow-derived multipotent mesenchymal stem cells.

Barlow S, Brooke G, Chatterjee K, Price G, Pelekanos R, Rossetti T, Doody M, Venter D, Pain S, Gilshenan K, Atkinson K.

Stem Cells Dev. 2008 Dec;17(6):1095-107. doi: 10.1089/scd.2007.0154.

PMID:
19006451
14.

Characterization and expansion of mesenchymal progenitor cells from first-trimester chorionic villi of human placenta.

Poloni A, Rosini V, Mondini E, Maurizi G, Mancini S, Discepoli G, Biasio S, Battaglini G, Berardinelli E, Serrani F, Leoni P.

Cytotherapy. 2008;10(7):690-7. doi: 10.1080/14653240802419310.

PMID:
18985476
15.

Isolation and characterization of mesenchymal cells from human fetal membranes.

Soncini M, Vertua E, Gibelli L, Zorzi F, Denegri M, Albertini A, Wengler GS, Parolini O.

J Tissue Eng Regen Med. 2007 Jul-Aug;1(4):296-305.

PMID:
18038420
16.

Concise review: isolation and characterization of cells from human term placenta: outcome of the first international Workshop on Placenta Derived Stem Cells.

Parolini O, Alviano F, Bagnara GP, Bilic G, Bühring HJ, Evangelista M, Hennerbichler S, Liu B, Magatti M, Mao N, Miki T, Marongiu F, Nakajima H, Nikaido T, Portmann-Lanz CB, Sankar V, Soncini M, Stadler G, Surbek D, Takahashi TA, Redl H, Sakuragawa N, Wolbank S, Zeisberger S, Zisch A, Strom SC.

Stem Cells. 2008 Feb;26(2):300-11. Review.

17.

Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue.

Wolbank S, Peterbauer A, Fahrner M, Hennerbichler S, van Griensven M, Stadler G, Redl H, Gabriel C.

Tissue Eng. 2007 Jun;13(6):1173-83.

PMID:
17518752
18.

Term Amniotic membrane is a high throughput source for multipotent Mesenchymal Stem Cells with the ability to differentiate into endothelial cells in vitro.

Alviano F, Fossati V, Marchionni C, Arpinati M, Bonsi L, Franchina M, Lanzoni G, Cantoni S, Cavallini C, Bianchi F, Tazzari PL, Pasquinelli G, Foroni L, Ventura C, Grossi A, Bagnara GP.

BMC Dev Biol. 2007 Feb 21;7:11.

19.

Isolation of amniotic stem cell lines with potential for therapy.

De Coppi P, Bartsch G Jr, Siddiqui MM, Xu T, Santos CC, Perin L, Mostoslavsky G, Serre AC, Snyder EY, Yoo JJ, Furth ME, Soker S, Atala A.

Nat Biotechnol. 2007 Jan;25(1):100-6.

PMID:
17206138
20.

Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts.

Ferretti C, Bruni L, Dangles-Marie V, Pecking AP, Bellet D.

Hum Reprod Update. 2007 Mar-Apr;13(2):121-41. Review.

Items per page

Supplemental Content

Support Center